Lung Adenocarcinoma Whole Blood

<h2>Lung Adenocarcinoma Whole Blood for Research</h2>
Lung adenocarcinoma is the most common subtype of non-small cell lung cancer, frequently driven by EGFR, KRAS, or ALK alterations that guide targeted therapy selection. Sanguine collects fresh whole blood from IRB-consented donors with a clinically confirmed lung adenocarcinoma diagnosis for oncology genomics research.
<h3>Product Features</h3>
<ul><li>Fresh whole blood from clinically diagnosed lung adenocarcinoma donors</li><li>Custom anticoagulants and collection tubes available</li><li>Same-day collection and shipment</li><li>Research Use Only (RUO)</li></ul>
<h3>De-identified Donor Data</h3>
<ul><li>Physician-confirmed diagnosis, including EGFR/KRAS/ALK status where available</li><li>Demographics: age, sex assigned at birth, ethnicity, smoking status</li><li>Relevant medical and treatment history</li></ul>
<h3>Applications</h3>
<ul><li>EGFR/KRAS/ALK mutation and targeted therapy research</li><li>Circulating tumor DNA and liquid-biopsy studies</li><li>Gene expression and transcriptomic analysis</li><li>Tyrosine kinase inhibitor response research</li></ul>
<h3>Also Available</h3>
Looking for other lung cancer types? See our <a href=”https://sanguinebio.com/product/non-small-cell-lung-cancer-whole-blood/”>Non-Small Cell Lung Cancer Whole Blood</a> product.
<h3>Compliance and Quality</h3>
<ul><li>IRB-approved protocols and electronic informed consent</li><li>HIPAA-compliant donor data handling</li></ul>
<h3>Ordering and Customization</h3>
Lung adenocarcinoma whole blood is available in standard and custom volumes. Email <a href=”mailto:learnmore@sanguinebio.com”>learnmore@sanguinebio.com</a> for international orders or documentation requirements.

Whole Blood

Frequently Asked Questions

Showing 13–24 of 26 results

Do samples come with donor screening reports?

1 Answer

All our samples have self-reported infectious disease testing and verified clinical diagnosis. Many of our samples have the option of electronic medical records provided and our prospective collection offers the opportunity for patient reported outcomes and surveys. Learn more here. https://sanguinebio.com/patient-reported-outcomes-pro-surveys-questionnaires/

YES – Certificate of analysis is available upon request.

Lead times vary from ready to ship inventory to prospective studies.

International shipping is available. We also work with a number of distributors. Contact us to discuss options at learnmore@sanguinebio.com.

We have several ordering methods. You can order directly online with a PO or credit card or contact us to have a sales specialist help with your order. https://sanguinebio.com/request-quote/

You can request a quote on this page or contact us at learnmore@sanguinebio.com. https://sanguinebio.com/request-quote/

NO – no minimum order requirements.

For bulk pricing inquiries, please contact: LearnMore@sanguinebio.com

YES, in some cases we can accomodate this request including treatment naive oncology samples. As we have electronic medical records, we can also accomodate specific treatment regiments.

YES – Donor metadata includes: gender, race/ethnicity, age, medications, healthcare encounters, and more. To learn more visit https://sanguinebio.com/donor-data/

Custom volumes available – The website consistently mentions “custom volumes” are available. You should contact learnmore@sanguinebio.com to discuss specific volume requirements and multiple units from the same donor.

Sanguine offers same-day delivery in many metropolitan areas. Whole Blood ships same day with next-day delivery options available. For more information, request a quote or contact: LearnMore@sanguinebio.com

1 2 3
×

Ask a Question

Need a custom Whole Blood cohort?

Our scientific team can scope prospective collections with donor-specific I/E criteria, typically starting within 2 weeks of agreement.

More Information